Show Summaries | Hide Summaries
We currently have no Breaking News on this stock.
SUPN vs. ETF Alternatives
Supernus Pharmaceuticals Incis a specialty pharmaceutical company. The Company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders.
Other News & PR